The high prevalence, incidence and mortality rates of prostate cancer in Tobago would appear to strongly indicate that screening of this population would be justified and could positively impact on mortality.
We consider our approach to be consonant with the recommendations of the EAU (Heidenreich A et al, 2013) and the findings of Hugosson et al, 2014).
Written by:
Patrick A, Bunker C, Nelson J, Dhir R, Wheeler V, Zmuda J, Richard JR, Belle A, Kuller L. Are you the author?
Tobago Health Studies Office, Scarborough, Tobago, Trinidad & Tobago; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh PA, USA.
Reference: BJU Int. 2014 Jul 21. Epub ahead of print.
doi: 10.1111/bju.12869
PubMed Abstract
PMID: 25046681
UroToday.com Prostate Cancer Section
